Transplantation

Thrombalexins protect renal allografts

Researchers have used a membrane-localizing technology to generate a novel class of thrombin inhibitors, named thrombalexins (TLNs), that bind to cell surfaces and could potentially be used to prevent acute antibody-mediated thrombosis in donor organs. In a rat renal allograft model of hyperacute antibody-mediated rejection, perfusion of donor kidneys with TLN-1 before transplantation substantially reduced intragraft thrombosis and increased graft survival.

References

  1. 1

    Karegli, J. et al. Thrombalexins: cell-localized inhibition of thrombin and its effects in a model of high-risk renal transplantation. Am. J. Transplant. http://dx.doi.org/10.1111/ajt.13951 (2016)

Download references

Authors

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Carney, E. Thrombalexins protect renal allografts. Nat Rev Nephrol 12, 510 (2016). https://doi.org/10.1038/nrneph.2016.117

Download citation